Loading...
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
PURPOSE: Sensitivity to a tyrosine kinase inhibitor (TKI) is correlated with the presence of somatic mutations that affect the kinase domain of epidermal growth factor receptor (EGFR). Development of resistance to TKI is a major therapeutic problem in non-small cell lung cancer (NSCLC). Aim of this...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer-Verlag
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3636434/ https://ncbi.nlm.nih.gov/pubmed/23515752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2132-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|